Begoña Oliver Martos-rekin lankidetzan egindako argitalpenak (5)

2021

  1. Soluble Receptor Isoform of IFN-Beta (sIFNAR2) in Multiple Sclerosis Patients and Their Association With the Clinical Response to IFN-Beta Treatment

    Frontiers in Immunology, Vol. 12

2020

  1. Predictive factors and early biomarkers of response in multiple sclerosis patients treated with natalizumab

    Scientific Reports, Vol. 10, Núm. 1

2014

  1. HLA alleles as biomarkers of high-titre neutralising antibodies to interferon-ß therapy in multiple sclerosis

    Journal of Medical Genetics, Vol. 51, Núm. 6, pp. 395-400

  2. Natalizumab-related anaphylactoid reactions in MS patients are associated with HLA class II alleles

    Neurology: Neuroimmunology and NeuroInflammation, Vol. 1, Núm. 4

2012

  1. ANKRD55 and DHCR7 are novel multiple sclerosis risk loci

    Genes and Immunity, Vol. 13, Núm. 3, pp. 253-257